Title: |
Outcomes of advanced renal cell carcinoma patients (aRCC) treated with mammalian target of rapamycin inhibitor (mTORi) therapy following first-line pazopanib (PAZ) in a US Community Oncology Setting |
Dateline: |
2014-09-26
DisplayDateline
|
Byline: |
Hutson TE, Hackshaw MD, Vogelzang NJ, Bhowmik D, Yap M, Rembert D, Jonasch E |
Publication Title: |
ESMO
|
CTA Link: |
https://www.sciencedirect.com/science/article/pii/S0923753419522621 |
CTA Text: |
Read More |
Filter(s):* This
creates the tags that filter the listing page by specific taxonomies that display to the right of the
main content and read more link.
|
-
|